top | item 24224657

(no title)

Medicalidiot | 5 years ago

Malaria is probably going to be one of the hardest maladies to overcome. There was some promise with a vaccine, but it looks like that was fairly disappointing. The selective pressure is so high with malaria that sickle cell anaemia is a fairly common congenital disease that if one is homozygous for can be lethal in early age; conventional medicine has significantly increased life expectancy, but it's still fairly poor. Hopefully, it will be to the point where it can be controlled because the African continent has had its economies ravaged by it.

https://en.wikipedia.org/wiki/Malaria#Economic_impact

discuss

order

filleduchaos|5 years ago

> A comparison of average per capita GDP in 1995, adjusted for parity of purchasing power, between countries with malaria and countries without malaria gives a fivefold difference (US$1,526 versus US$8,268). In the period 1965 to 1990, countries where malaria was common had an average per capita GDP that increased only 0.4% per year, compared to 2.4% per year in other countries.

That seems like a really egregious case of conflating correlation with causation.

sonicggg|5 years ago

But I wonder how much effort is being put into it though. Take the Sars outbreak. They tried developing a vaccine, and failed. Everybody just assumed it was impossible to create a vaccine for a coronavirus, as we never had one anyway.

Now with Covid-19, we have multiple vaccines in the third, and final, stage of testing. And we also have a controversial vaccine that has been approved in Russia. All within a couple of months. Why that hasn't been achieved with Sars?

dflock|5 years ago

SARS fizzled out, so we lost interest and funding was cut.

triceratops|5 years ago

SARS died down before they could develop a vaccine. After that it's kinda hard to do human trials without deliberately infecting someone.